ABRAXIS BIOSCIENCE, LLC v. JIANGSU HENGRUI PHARMACEUTICALS CO., LTD.

3:2022-cv-02745

ANDA

Bio-Tech

Cause of ActionLogin To View

Appeal NumberLogin To View

StatusLogin To View

OutcomeSubscription-Only

Patent

1

Filing DateMay 11, 2022

Termination DateLogin To View

CourtLogin To View

JudgesLogin To View

Case LengthLogin To View

Technology Center-

Plaintiff

1

Bristol Myers Squibb

Defendant

1

Jiangsu Hengrui Pharmaceuticals Co. Ltd.

ANDA report image

Empower your practice with Patexia ANDA IP Module.

Get access to our exclusive rankings and unlock powerful data.

Check our Latest Report Purchase IP Module

Looking for a ANDA Attorney & Experts?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.